Shouse G, Chen L, Siddiqi T, Muir A, et al. A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Leuk Lymphoma 2024 Jun 5:1-4. doi: 10.1080/10428194.2024.2361841.
PMID: 38836342